Cyst formation following disruption of intracellular calcium signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 39, 2014, Pages 14283-14288

  Kuo, Ivana Y ^a   DesRochers, Teresa M ^b   Kimmerling, Erica P ^b   Nguyen, Lily ^a   Ehrlich, Barbara E ^a   Kaplan, David L ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tufts University   (United States)

Author keywords

Calcium release; Polycysin 2; Primary cilia

Indexed keywords

CULTURE MEDIUM; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CALCIUM SIGNALING; CULTURE MEDIUM; CULTURE TECHNIQUE; DEFICIENCY; EUKARYOTIC FLAGELLUM; GENE SILENCING; GENETICS; HUMAN; KIDNEY; KIDNEY POLYCYSTIC DISEASE; KNOCKOUT MOUSE; LLC PK1 CELL LINE; MALE; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PIG;

ANIMALS; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; CILIA; CULTURE MEDIA; GENE KNOCKDOWN TECHNIQUES; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; KIDNEY; LLC-PK1 CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; SWINE; TRPP CATION CHANNELS;

EID: 84907584688     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1412323111     Document Type: Article

References (65)

1. Baert L (1978) Hereditary polycystic kidney disease (adult form): A microdissection study of two cases at an early stage of the disease. Kidney Int 13(6):519-525.
2. Grantham JJ (1983) Polycystic kidney disease: A predominance of giant nephrons. Am J Physiol 244(1):F3-F10.
3. Grantham JJ (1997) Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int Suppl 63:S93-S97.
4. Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89(4): 1341-1378.
5. Kuo IY, Ehrlich BE (2012) Ion channels in renal disease. Chem Rev 112(12):6353-6372.
6. Bukanov NO, et al. (2002) Functional polycystin-1 expression is developmentally regulated during epithelial morphogenesis in vitro: Downregulation and loss of membrane localization during cystogenesis. Hum Mol Genet 11(8):923-936.
7. Li H, Findlay IA, Sheppard DN (2004) The relationship between cell proliferation, Clsecretion, and renal cyst growth: A study using CFTR inhibitors. Kidney Int 66(5): 1926-1938.
8. Orellana SA, Marfella-Scivittaro C (2000) Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones. J Biol Chem 275(28):21233-21240.
9. Bukanov NO, et al. (2012) CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. Cell Cycle 11(21): 4040-4046.
10. Liu B, Li C, Liu Z, Dai Z, Tao Y (2012) Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. BMC Nephrol 13:109.
11. Takiar V, et al. (2011) Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci USA 108(6):2462-2467.
12. Zhou H, et al. (2012) Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models. Am J Physiol Renal Physiol 302(10):F1234-F1242.
13. Carone FA, et al. (1995) Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys. Kidney Int 47(3):861-868.
14. Jansson K, et al. (2012) Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Am J Physiol Renal Physiol 303(7):F982-F990.
15. Reif GA, et al. (2011) Tolvaptan inhibits ERK-dependent cell proliferation, Cl secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am J Physiol Renal Physiol 301(5):F1005-F1013.
16. Swenson-Fields KI, et al. (2013) Macrophages promote polycystic kidney disease progression. Kidney Int 83(5):855-864.
17. Wallace DP, Grantham JJ, Sullivan LP (1996) Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 50(4):1327-1336.
18. Yamaguchi T, Reif GA, Calvet JP, Wallace DP (2010) Sorafenib inhibits cAMPdependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am J Physiol Renal Physiol 299(5):F944-F951.
19. Subramanian B, et al. (2010) Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A 16(9):2821-2831.
20. Sullivan LP, et al. (2002) Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst trowth by cultured ADPKD cells. J Am Soc Nephrol 13(11):2619-2627.
21. Desrochers TM, Palma E, Kaplan DL (2014) Tissue-engineered kidney disease models. Adv Drug Deliv Rev 69-70:67-80.
22. Koulen P, et al. (2002) Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4(3):191-197.
23. Anyatonwu GI, Estrada M, Tian X, Somlo S, Ehrlich BE (2007) Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc Natl Acad Sci USA 104(15): 6454-6459.
24. Cai Y, et al. (2004) Calcium dependence of polycystin-2 channel activity is modulated by phosphorylation at Ser812. J Biol Chem 279(19):19987-19995.
25. Subramanian B, et al. (2012) The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions. Biomaterials 33(33):8383-8394.
26. Mekahli D, et al. (2012) Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium 51(6):452-458.
27. Sammels E, et al. (2010) Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 285(24):18794-805.
28. Qian Q, et al. (2003) Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet 12(15):1875-1880.
29. Grimm DH, et al. (2006) Polycystin-2 regulates proliferation and branching morphogenesis in kidney epithelial cells. J Biol Chem 281(1):137-144.
30. Spirli C, et al. (2012) Altered store operated calcium entry increases cyclic 3,5- adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes. Hepatology 55(3): 856-868.
31. Shibao K, et al. (2010) The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. Cell Calcium 48(6):315-323.
32. Shibao K, Hirata K, Robert ME, Nathanson MH (2003) Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology 125(4):1175-1187.
33. Kruglov EA, Gautam S, Guerra MT, Nathanson MH (2011) Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes. Hepatology 54(5):1790-1799.
34. Celic AS, et al. (2012) Calcium-induced conformational changes in C-terminal tail of polycystin-2 are necessary for channel gating. J Biol Chem 287(21):17232-17240.
35. Kuo IY, et al. (2014) The number and location of EF hand motifs dictates the calcium dependence of polycystin-2 function. FASEB J 28(5):2332-2346.
36. Wohlwend A, Montesano R, Vassalli JD, Orci L (1985) LLC-PK1 cysts: A model for the study of epithelial polarity. J Cell Physiol 125(3):533-539.
37. DesRochers TM, Suter L, Roth A, Kaplan DL (2013) Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity. PLoS ONE 8(3):e59219.
38. Neufeld TK, et al. (1992) In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41(5):1222-1236.
39. Chuman L, Fine LG, Cohen AH, Saier MH, Jr (1982) Continuous growth of proximal tubular kidney epithelial cells in hormone-supplemented serum-free medium. J Cell Biol 94(3):506-510.
40. Wegierski T, et al. (2009) TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum. EMBO J 28(5):490-499.
41. Woo D (1995) Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333(1):18-25.
42. Kolb RJ, Nauli SM (2008) Ciliary dysfunction in polycystic kidney disease: An emerging model with polarizing potential. Front Biosci 13:4451-4466.
43. Zhou J (2009) Polycystins and primary cilia: Primers for cell cycle progression. Annu Rev Physiol 71:83-113.
44. Xu C, et al. (2007) Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am J Physiol Renal Physiol 292(3):F930-F945.
45. Pazour GJ, San Agustin JT, Follit JA, Rosenbaum JL, Witman GB (2002) Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol 12(11):R378-R380.
46. Delling M, DeCaen PG, Doerner JF, Febvay S, Clapham DE (2013) Primary cilia are specialized calcium signalling organelles. Nature 504(7479):311-314.
47. DeCaen PG, Delling M, Vien TN, Clapham DE (2013) Direct recording and molecular identification of the calcium channel of primary cilia. Nature 504(7479):315-318.
48. Yoshiba S, et al. (2012) Cilia at the node of mouse embryos sense fluid flow for leftright determination via Pkd2. Science 338(6104):226-231.
49. Rodat-Despoix L, Delmas P (2009) Ciliar functions in the nephron. Pflugers Arch 458(1):179-187.
50. Raychowdhury MK, et al. (2009) Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells. Am J Physiol Renal Physiol 296(1): F87-F97.
51. Natoli TA, et al. (2008) Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am J Physiol Renal Physiol 294(1):F73-F83.
52. Ma M, Tian X, Igarashi P, Pazour GJ, Somlo S (2013) Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 45(9): 1004-1012.
53. Pan J, Seeger-Nukpezah T, Golemis EA (2013) The role of the cilium in normal and abnormal cell cycles: Emphasis on renal cystic pathologies. Cell Mol Life Sci 70(11): 1849-1874.
54. Sung CH, Li A (2011) Ciliary resorption modulates G1 length and cell cycle progression. Cell Cycle 10(17):2825-2826.
55. Kim S, Tsiokas L (2011) Cilia and cell cycle re-entry: More than a coincidence. Cell Cycle 10(16):2683-2690.
56. Wallace DP (2011) Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta 1812(10): 1291-1300.
57. Torres VE, Harris PC (2014) Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol 25(1):18-32.
58. Foskett JK, White C, Cheung KH, Mak DO (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87(2):593-658.
59. Colosetti P, et al. (2003) The type 3 inositol 1,4,5-trisphosphate receptor is concentrated at the tight junction level in polarized MDCK cells. J Cell Sci 116(Pt 13):2791-2803.
60. Hirata K, et al. (2002) Regulation of Ca(2+) signaling in rat bile duct epithelia by inositol 1,4,5-trisphosphate receptor isoforms. Hepatology 36(2):284-296.
61. Smedler E, Uhlén P (2014) Frequency decoding of calcium oscillations. Biochim Biophys Acta 1840(3):964-969.
62. Matsumoto M, et al. (1996) Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379(6561):168-171.
63. Hayashi M, et al. (1999) Intracellular calcium concentration in the inositol trisphosphate receptor type 1 knockout mouse. J Am Soc Nephrol 10(10):2094-2101.
64. Futatsugi A, et al. (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309(5744):2232-2234.
65. Song X, et al. (2009) Systems biology of autosomal dominant polycystic kidney disease (ADPKD): Computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18(13):2328-2343.